Wellmune WGP®, the immune health ingredient for foods, beverages and supplements from Biothera, has been named a recipient of a 2011 SupplySide West Scientific Excellence Award.
Virgo Publishing announced today that Wellmune WGP will be honored at an awards ceremony at 2:00 pm on Wednesday, October 12 in the Virgo booth (#22061) at SupplySide West in Las Vegas at The Venetian & Sands Expo.
A panel of industry experts evaluated award submissions on the basis of science/research methods, scientific breakthrough, innovation and appeal for the manufacturing community. The Wellmune technology has been the subject of 30 peer-reviewed articles over the past decade, including six publications or scientific conference presentations of original clinical research in the 2010-2011. In announcing Wellmune’s selection for an award this year, Virgo Publishing stated: “All of these well-designed human clinical trials consistently demonstrated significant health benefits, including improved physical health, reduced upper respiratory track infection symptoms and improved well-being.”
“We are honored that Wellmune WGP has received this prestigious award,” said Rich Mueller, Biothera chief executive officer. “This award is further recognition of Biothera’s strong commitment to an ongoing clinical research program that supports the use of Wellmune WGP as a unique food, beverage and supplement ingredient.”
Wellmune WGP has previously received an Innovation Award from the Institute of Food Technologists and a Frost & Sullivan Excellence in Research Award.
Virgo Publishing also stated: “This technology has captured mainstream scientific community interest as evidenced by the April cover story in the journal Nature further elucidating the mechanism of action of Wellmune WGP. Additional knowledge of how Wellmune WGP works in the body was published in the June issue of the journal Blood, making Wellmune one of the best characterized and mechanistically understood ingredients in the natural products industry.” Biothera’s research collaborations include leading institutions, such as UCLA medical center, Scripps Institute, Southampton University Hospital (UK), University of Louisville, Ohio State University and University of Houston.
“Our team of chemists, biologists and immunologists have developed novel analytical methods and conducted numerous toxicology, mechanism of action and preclinical studies,” said Don Cox, Ph.D., senior vice president, Biothera research and development. “We also have a large number of active research collaborations that have also further advanced the science of Wellmune WGP.”
About Wellmune WGP
Wellmune WGP is a natural ingredient that is clinically proven to safely prime the immune system to keep the body healthy. Wellmune WGP is a proprietary baker’s yeast beta glucan that mobilizes billions of innate immune cells that are part of the body’s natural defenses. This unique immune health ingredient helps increase their effectiveness without stimulating the immune system. Wellmune WGP isGenerally Recognized as Safe (GRAS) under U.S. FDA regulations and has broad regulatory approval worldwide. It is also patented, Kosher, Halal, non-allergenic, GMO-free. Wellmune WGP is an ingredient in products in more than 30 countries.
About Biothera, the immune health company
Biothera is a biotechnology company dedicated to improving immune health. The company’s Healthcare Group is a leading provider of natural immune health ingredients for the functional food and beverage, dietary supplement, cosmetic and animal nutrition markets. Biothera’s flagship ingredient is Wellmune WGP, a unique food, beverage and supplement ingredient. More information is available at www.wellmune.com.